Unbiased Analysis of Today's Healthcare Issues
One piece of the Affordable Care Act (ACA) mandated that health insurance plans for individuals with yearly premiums exceeding $10,200 or family health insurance plans with premiums exceeding $27,500 would be subject to a tax. The tax originally was set to start in 2018, but has since been postponed to 2022. The Kaiser Family Foundation…
Louisiana has already begun adopting a “Netflix” pricing model to pay for Hepatitis C treatments. Rather than pay per treatment, Louisiana would pay a flat rate per month to access as many Hepatitis C treatments as they need. The benefit of this is (i) states have predictable budgets and (ii) manufacturers have predicable revenues. This…
How accurate are RVUs? Capturing the patient voice. Tools for physicians to find patient copays for drugs. New generic EpiPen hits the market. An honest man. Is Mechanical Turk trustworthy for surveys?
What will Trump’s “favored nation” policy do to drug prices and innovation? How will 340B reforms affect the price hospitals charge for drugs? Myself and my colleague Jim Baumgardner weigh in with our thoughts in an article in FormularyWatch. “US drug prices will certainly fall. However, prices outside the US will rise,” Jason Shafrin, PhD,…
Today I put together the journal round-up for the Academic Health Economists’ blog, one of my favorite reads. I review three papers: Understanding price growth in the market for targeted oncology therapies. American Journal of Managed Care [PubMed] Published 14th June 2019 Do cancer treatments have option value? Real‐world evidence from metastatic melanoma. Health Economics [PubMed]…
A typical answer is that the cost of R&D is very high. However, an interesting book by–César Hidalgo titled Why Information Grows–offers a more conceptual rationale. Medicinal pills embody little information, as their active compound is usually a small and relative simple molecule. Yet medicinal pills can be extremely useful and valuable. Why? To understand…
We are getting close to eradicating polio…but we are not there yet. That is why a recent article in this week’s Economist on polio vaccination in Pakistan is so troubling. Worried parents began arriving at hospitals in ones and twos, then dozens and soon hundreds. Each was convinced their child was sick, poisoned by polio…
Not surprisingly, the answer is yes, but not by as much as one might guess. In part due to a measles outbreak at Disneyland, California outlawed non-medical exemptions for vaccinations. An NBER working paper by Richwine et al. (2019) provides background on the situation in California prior to enacting the ban. Prior to the policy…
My former colleague Devin Incerti has a nice summary of how to implement survival function estimation in R. Not only does he mathematically describe the probability density function (PDF), cumulative density function (CDF), and hazard rates for 8 commonly used parametric survival curves [see table below], he also describes how to implement these using the…
Electronic health records (EHR) have the potential to greatly improve the quality of care. EHRs allow multi-specialty teams to access the same underlying medical information and eliminate the issue of miscommunication due to poor physician hand writing. At the same time, EHR increase data entry burden. Is the benefit of EHR worth the cost? One…